CPHI vs SOFI · rev $4.1M vs P/E 39, rev $619.4M
China Pharma Holdings Inc (CPHI) versus SoFi Technologies Inc. (SOFI) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
SoFi Technologies Inc. (SOFI) is a credit services company listed on NASDAQ.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported SOFI revenue for 2025-12-31 was $619.4M. Net income was $481.3M. Revenue was up 23.1% from 2024-12-31 to 2025-12-31. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
CPHI currently screens at market cap $29.0M. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
Not investment advice. Open the CPHI and SOFI stock pages for the full models.
Not investment advice.